Accessibility Menu

West Pharmaceutical Services(FRA) WPS

Market Cap€20.73BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€288.60
-2.04%
-6.00Today

West Pharmaceutical Services Financials at a Glance

Market Cap

€20.73BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.85K

Net Income (TTM)

€484.38

EPS (TTM)

€6.71

P/E Ratio

43.92

Dividend

€0.76

Beta (Volatility)

-0.07 (Low)

Price

€288.60

Volume

0

Open

€288.60

Previous Close

€288.60

Daily Range

€288.60 - €288.60

52-Week Range

€191.35 - €340.00

Estimated Earnings Date

N/A

WPS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

10,800

CEO

Eric Mark Green, MBA

Website

www.westpharma.com

WPS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

18.96%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.28%

Dividend Yield

0.26%

Payout Ratio

N/A

Stock Overview

Market Cap

€20.73BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.38M

Volume

0

Avg. Volume

0.349

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

West Pharmaceutical Services Performance Analysis

West Pharmaceutical Services annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 2,745,547,58814.6%
20232023-12-31EUR 2,729,680,334-0.6%
20242024-12-31EUR 2,674,239,364-2.0%
20252025-12-31EUR 2,724,401,9771.9%
West Pharmaceutical Services annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 7.350.2%
20232023-12-31EUR 7.29-0.9%
20242024-12-31EUR 6.18-15.2%
20252025-12-31EUR 6.02-2.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€750.32

+1.1%

Gross Profit

€283.82

+1.2%

Gross Margin

37.83%

+1.1%

Market Cap

€20.73BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€2.03

N/A

Employees

10,800

N/A

Net Income

€132.45

+1.1%

EBITDA

€210.28

+1.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€658.01

-5.6%

Total Debt

€276.83

+1.1%

Accounts Receivable

€637.80

+1.2%

Inventory

€391.32

+1.1%

Long Term Debt

€257.33

+1.1%

Short Term Debt

€19.50

+1.0%

Return on Assets

13.97%

+1.0%

Return on Invested Capital

18.99%

+1.0%

Free Cash Flow

€69.74

+0.8%

Operating Cash Flow

€107.12

+0.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About WPS

What is the current price of West Pharmaceutical Services?

West Pharmaceutical Services is trading at €288.60 per share.

What is the 52-week range for West Pharmaceutical Services?

Over the past 52 weeks, West Pharmaceutical Services has traded between €191.35 and €340.00.

How much debt does West Pharmaceutical Services have?

As of the most recent reporting period, West Pharmaceutical Services reported total debt of €276.83M.

How much cash does West Pharmaceutical Services have on hand?

West Pharmaceutical Services reported €381.18M in cash and cash equivalents in its most recent financial results.

What is West Pharmaceutical Services’s dividend yield?

West Pharmaceutical Services currently has a dividend yield of 0.26%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services